Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hong Kong Clears Europharm Products Of Fungus, Plant Still Shut

This article was originally published in PharmAsia News

Executive Summary

Hong Kong health authorities have now cleared all 359 of Europharm's drug products of containing a fungal growth found in gout products. Although the Hong Kong Department of Health said it plans to continue testing, it said examinations of 39 raw material samples from the drug maker uncovered none of the Rhizopus microsporus fungus implicated in at least six Hong Kong fatalities. But the department also said Europharm could not resume manufacturing operations until it has improved its production lines to the satisfaction of authorities. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts